About us Pricing ContactSubscribe

C

C. Paul

Université Toulouse III - Paul SabatierORCID https://orcid.org/0000-0003-0165-5263

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

British Journal of Dermatology2015472 citationsFirst authorCorresponding

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

British Journal of Dermatology2016450 citations

C. Paul · Scinovex